A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

Clinical trial NCT07215702 · RECRUITING

Trial details

NCT number: NCT07215702
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sepsis Acute Kidney Injury

Start date: 2026-02-10
Primary completion: 2027-02-11
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.